More than 460 laid-off employees at the US Centers for Disease Control and Prevention are being rehired, officials said June 11.

Researchers found that during 2020 to 2022, tooth disorders accounted for an annual average of 1,944,000 emergency department visits. HealthDay News — Tooth disorders accounted for an annual average ...

Prepandemic severe spirometric obstruction, spirometric restriction, and increased emphysema on CT are linked to higher risk for severe COVID-19.

Church & Dwight has initiated a recall of all lots within expiry of Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs, and Orajel Baby Teething Swabs due to potential microbial contamination.

A vaccine critic hired by RFK Jr is reviewing safety data in an effort to revisit debunked claims that vaccines may cause autism.

HHS Secretary Robert F. Kennedy Jr named 8 new members to the CDC’s Advisory Committee on Immunization Practices.

In patients with COVID-19, preexisting immunity and Omicron infection were associated with reduced disease severity and upper respiratory symptom presentation.

FDA drug alerts in infectious diseases, including new drug approvals, safety warnings, recalls, and changes in indications.

Clinical use of AI-generated draft radiograph reports is associated with improved radiologist documentation efficiency.

More than 1.7 million window air conditioners are being recalled due to a risk for mold growth, which can lead to serious health problems.

Treatment with RBL was effective against recurrent CDI among high-risk patients when administered at home or in clinical settings.

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.